F3 Logic, LLC Amarin Corp Plcuk Transaction History

F3 Logic, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$4.04 - $5.31 $202 - $265	-50 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$3.64 - $7.76 $61,687 - $131,508	-16,947 Reduced 99.71%	50 $211,000
Q2 2020 Aug 10, 2020	SELL	$4.78 - $8.26 $478 - $826	-100 Reduced 0.58%	16,997 $117,000
Q1 2020 Apr 16, 2020	BUY	$4.0 - $21.53 $800 - $4,306	200 Added 1.18%	17,097 $67,000
Q4 2019 Jan 13, 2020	BUY	$13.94 - $24.12 $2,091 - $3,618	150 Added 0.9%	16,897 $362,000

Q3 2019 Nov 08, 2019	BUY	$13.89 - $23.16 $58,782 - $98,013	4,232 Added 33.82%	16,747 $254,000
Q1 2019 May 06, 2019	BUY	$12.61 - $22.33 $11,664 - $20,655	925 Added 7.98%	12,515 $261,000
Q4 2018 Feb 08, 2019	BUY	$12.41 - $22.98 $143,831 - $266,338	11,590 New	11,590 $158,000

184

87.9M

528K

219K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $282M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of F3 Logic, LLC, based on Form 13F filings with the SEC.

Stay updated on F3 Logic, LLC with notifications on news.